局部淋巴结试验
效力
医学
皮肤致敏
敏化
人体皮肤
体内
药理学
毒理
计算生物学
体外
免疫学
生物化学
生物技术
生物
遗传学
作者
David A. Basketter,Nathalie Alépée,Takao Ashikaga,José G. Barroso,N. Gilmour,Carsten Goebel,Jalila Hibatallah,Sebastian Hoffmann,Petra Kern,Silvia Martinozzi-Teissier,Gavin Maxwell,Kerstin Reisinger,Hitoshi Sakaguchi,Andreas Schepky,Magalie Tailhardat,Marie Templier
出处
期刊:Dermatitis
[Ovid Technologies (Wolters Kluwer)]
日期:2014-01-01
卷期号:25 (1): 11-21
被引量:207
标识
DOI:10.1097/der.0000000000000003
摘要
Although adoption of skin sensitization in vivo assays for hazard identification is likely to be successful in the next few years, this does not replace their use in potency prediction. Notably, measurement of potency of skin sensitizers in the local lymph node assay has been important. However, this local lymph node assay potency measure has not been formally assessed against a range of substances of known human sensitizing potential, because the latter is lacking. Accordingly, criteria for human data have been established that characterize 6 categories of human sensitizing potency, with 1 the most potent and 5 the least potent; category 6 represents true nonsensitizers. The literature has been searched, and 131 chemicals assigned into these categories according to their intrinsic potency judged only by the available human information. The criteria and data set generated provide a basis for examination of the capacity of nonanimal approaches for the determination of human sensitization potency.
科研通智能强力驱动
Strongly Powered by AbleSci AI